Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Baricitinib is the most effective treatment for alopecia areata.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Baricitinib may not always prevent relapse in alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.